摘要
乙型肝炎病毒(hepatitis B virus,HBV)感染可致患者免疫紊乱,并产生自身抗体,包括器官特异性自身抗体和器官非特异性自身抗体。器官特异性自身抗体主要有抗肝特异性脂蛋白(liver specific lipoprotein,LSP)及抗肝细胞膜抗原(liver membrane antigen,LMA),器官非特异性自身抗体包括抗核抗体(anti-nuclear antibody,ANA)、抗平滑肌抗体(an-ti-smooth muscle antibody,ASMA)、抗细胞骨架抗体(anti-cytoskeleton,CS)、抗线粒体抗体(anti-mitochondria antibody,AMA)等。对自身抗体的检测有利于分析和评价乙型肝炎(简称乙肝)患者体内自身免疫状况,并为临床治疗方案的制定提供参考依据。
Hepatitis B virus（HBV） infection can cause immune disorders,and produce their own antibodies,including organ-specific autoantibodies and organ non-specific autoantibodies.Organ specific autoantibodies are mainly anti-LSP and an-ti-LMA and non-organ specific autoantibodies include anti-nuclear antibody（ANA）,anti-cytoskeleton（CS）,anti-smooth muscle antibody（ASMA）,anti-mitochondria antibody（AMA）,etc.The detection of autoantibodies benefits the analysis and evaluation of the body own immune status in the patients with hepatitis B and provides reference evidence for formulating the treatment scheme in clinic.
出处
《现代医药卫生》
2012年第1期89-90,共2页
Journal of Modern Medicine & Health
